Related Experiment Video

Updated: Jul 16, 2026

Spatial and Temporal Analysis of Active ERK in the C. elegans Germline
08:40

Spatial and Temporal Analysis of Active ERK in the C. elegans Germline

Published on: November 29, 2016

Spatial regulation of EGFR signaling by Sprouty2

Hong Joo Kim1, Laura J Taylor, Dafna Bar-Sagi

  • 1Graduate Program in Molecular and Cellular Biology, State University of New York at Stony Brook, Stony Brook, NY 11794-5222, USA.

Current Biology : CB
|February 27, 2007
PubMed

Insights

Human Sprouty 2 (hSpry2) protein blocks epidermal growth factor receptor (EGFR) signaling by interfering with its endocytic trafficking. This discovery reveals a new mechanism controlling EGFR compartmentalization and intracellular signal propagation.

Area of Science:

  • Cell biology
  • Molecular signaling
  • Endocytosis research

Background:

  • Epidermal growth factor receptor (EGFR) activation triggers signaling pathways and receptor trafficking to endosomes.
  • Endocytic transport's role in signal specification is increasingly recognized, but molecular mechanisms remain unclear.
  • Sprouty 2 (hSpry2) is known to negatively regulate receptor tyrosine kinase (RTK) signaling.

Purpose of the Study:

  • To investigate the molecular mechanisms linking endocytic transport and EGFR signal specification.
  • To determine the role of human Sprouty 2 (hSpry2) in EGFR trafficking and signaling.

Main Methods:

  • Investigated the interaction between hSpry2 and the endocytic machinery.
  • Analyzed the effect of hSpry2 on EGFR localization and trafficking dynamics.
  • Studied the impact of hSpry2 on downstream signaling events.

Main Results:

  • hSpry2 inhibits activated EGFR trafficking from early to late endosomes.
  • hSpry2 binds to hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs), an endocytic regulator.
  • This interaction blocks intracellular signal propagation from EGFR.

Conclusions:

  • EGFR signaling is regulated by a novel mechanism involving trafficking-dependent changes in receptor compartmentalization.
  • hSpry2 acts as a molecular link between EGFR trafficking and signal termination.

More Related Videos

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...